Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting 18kDa Translocator Protein (TSPO) to Improve Brain Endothelial Cell Function in Cerebral Small Vessel Disease

NCT06643013 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT06643013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06643013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting 18kDa Translocator Protein (TSPO) to Improve Brain Endothelial Cell Function in Cerebral Small Vessel Disease
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2024
Completion date
April 30, 2028
Enrollment
106 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral small vessel disease